Term
2. List and describe the primary channel or receptor mechanisms by which Vaughn-Williams classification I, II, III, and IV antiarrhythmic medications produce their effect.
|
|
Definition
(i) Class Ia = sodium (intermediate); potassium (ii) Class Ib = sodium (fast on/off) (iii) Class Ic = sodium (slow on/off); potassium (iv) Class II = calcium (indirect)- these drugs are also known as the “beta blockers” (v) Class III = potassium (vi) Class IV = calcium
|
|
|
Term
i) Discuss 6 agents that may cause drug induced torsade de pointes and ii)treatment of torsade de pointes.
|
|
Definition
i) 1. Quinidine 2. Ibutilide (Corvert®) 3. Dofetilide (Tikosyn®) 4. Phenothiazines 5. Antihistamines 6. Antidepressants (ii) Treatment = drug of choice is magnesium |
|
|
Term
Name some properties of Class 1a Antiarrhythmics |
|
Definition
Slow conduction velocity Prolong refractoriness Decrease the autonomic properties of sodium-dependant conduction tissue Intermediate “on/off” activity they are good for when you have an automatic process Not widely used due to risk of toxicity |
|
|
Term
Class 1a Toxic Effects: Quinidine = Procainamide = Disopyramide = |
|
Definition
Quinidine = Diarrhea, headache, Torsades de pointe Procainamide = Lupus-like syndrome Disopyramide = exacerbate heart failure, Anticholinergic effects (like antihistimine…dry mouth confusion)
|
|
|
Term
1) Class 1b Antiarrhythmic Properties 2) Name the 2 most commonly prescribed and their properties |
|
Definition
1) Used for emergent ventricular arrhythmias Very similar in action to Ia Fast “on/off” action = best effect on greatly increased heart rate 2) Lidocaine Short acting and can cause seizures Phenytoin (anti seizure drugs) Sodium channel blocker IV form has pH ~12
|
|
|
Term
1) Class Ic Properties 2) Name 2 1c drugs |
|
Definition
1) For Ventricular arrhythmias Increased slowing of conduction velocity as compared to other groups For refractory arrhythmias Relatively high incidence of proarrhythmia 2) Flecanide (Tambocor®) Propafenone (Rythmol®)
|
|
|
Term
1)Class II properties 2) Name some |
|
Definition
1) β1 receptor antagonists (also cause vasodilation) Don’t alter rhythm…just slow rate down. Used to control ventricular response to aberrant conduction signals 2)Propranolol (Inderal®) Esmolol (Brevibloc ®) Metoprolol (Lopressor ®, Toprol XL ®) Atenolol (Tenormin®) Bisoprolol (Ziac®)
|
|
|
Term
1) Class III Properties 2) Name some specific Class III and their properties |
|
Definition
1) Block potassium channels to prolong refractory period Proarrhythmic 2) Ibutilide (Corvert ®) Relatively high incidence of Torsade de pointes Sotalol (also a betablocker) Dofetilide (Tikosyn®) Increased risk of torsade de pointes Must monitor QTc and renal function during initiation for “chemical” cardioversion VERY NARROW THERAPEUTIC RANGE bc we have a QRS Widening. Multiple Drug-Drug InteractionCALL A PHARMACISTS Amiodarone IV or PO VERY COMMON USED. Very complex mechanism of action Very long t1/2!!!! WEEKS…these side effects last months
|
|
|
Term
1) Class IV Properties 2) Potential Downsides? |
|
Definition
1) Calcium Channel blockers Slows ventricular response 2) Can cause significant bradycardia and hypotension (not as bad as Betablockers though)
|
|
|
Term
1) Which drug blocks AV Nodal reentry halting paroxysmal supraventricular tachycardia (PSVT) 2) T or F..it has a very long half life 3) T or F...causes a temporary flatline? |
|
Definition
1) Adenosine (Adenocard ®) 2) False only 10 seconds so it must be injected very rapidly for desired effect. 3) T |
|
|
Term
Atrial Fib or FlutterRates 1) Fib = atrial BPM=? , ventricular response usually 120 – 180 BPM; irregular 2) Flutter = atriam BPM=? 3) Ventricular response in multiples of ___
|
|
Definition
1) 400 – 600 BPM 2) 280 – 320 BPM 3) 300 1:1 = VR 300 BPM 2:1 = VR 150 BPM 3:1 = VR 100 BPM |
|
|
Term
What might we do to treat A. Fib or A. Flutter? |
|
Definition
Treatment Beta blockers Cardioversion (30 W of Electrical Shock) Digoxin ??? Amiodarone Surgery
|
|
|
Term
Describe the results of the CAST trial and other clinical trials concerning current and future use of antiarrhythmic medications. (i) Enrolled _____ patients (ii) Low ejection fraction (<30-55%) (iii) Treated with class __agents vs. placebo to suppress ventricular arrhythmias (iv) __ fold higher mortality rate in treatment group
|
|
Definition
|
|
Term
In general when considering Ventricular Premature Beats our Motto should be what? |
|
Definition
Just say no to drugs (maybe a Betablocker....if the pain is really severe but that is IT) ....nothing what's the mada witchu? |
|
|
Term
1) Ventricular Tachycardia is considered SUSTAINED if it is greater than how many seconds? 2) Nonpharm Txs? 3) Pharm Txs? |
|
Definition
1) 30 2) Direct cardioversion Overdrive pacing Electrophysiologic study Implantable cardioverter defibrillator
3) Amiodarone Lidocaine Procainamide
|
|
|
Term
1) What is the Drug of Choice to treat Torsades De Pointe? 2) What types of ion deficiencies are associated with this condition? |
|
Definition
1) Drug of choice for treatment is MAGNESIUM (2 grams of Mag will set you free) 2) Hypokalemia...hypomagnesium |
|
|
Term
Bradyarrhythmia Treatments
|
|
Definition
Transvenous pacemaker therapy Correct electrolytes Remove offending agents Digoxin, beta-blocker, calcium channel blockers, clonidine, methyldopa, type Ia agents, amiodarone
|
|
|
Term
Receptors and their fcts: Alpha 1
Beta 1
Beta 2
|
|
Definition
Vasoconstriction Increase HR and contractility Increases HR and contractility AND VASODILATION |
|
|
Term
Receptors and their fcts: V1
DA
|
|
Definition
Vasoconstriction Vasodilation |
|
|
Term
What are 3 main causes of Shock |
|
Definition
1) Intravascular volume deficit (hypovolemic, hemorrhagic) 2) Myocardial failure (cardiogenic) 3) Peripheral vasodilation (septic, anaphylatic, neurogenic)
|
|
|
Term
1) T or F With Alubumin there is No difference in 28 day mortality when compared to NS for resuscitation of critically ill patients (SAFE trial) 2) What is Comparable to 5% albumin but Less expensive
|
|
Definition
1) True...but there IS a difference in cost...ALBUMIN is much more pricey 2) Hetastarch, but avoid in intracranial hemorrhage due to risk of decreased factor VII activity and watch out for renal damage (limit to 1.5 L a day to avoid damage here...large starch molecules) |
|
|
Term
1) Rank these in order of Vasoconstrictiveness Fcting: Dopamine Isoproterenol Phenylephrine Isoproterenol Dobutamine Norepinephrine 2) T/F HR effectiveness follows this same order? |
|
Definition
PNEDDI or Phenylephrine (most alpha) Norepinephrine Epinephrine Dopamine Dobutamine Isoproterenol (most beta) 2) False Inverse...most beta-like are more effective HR effectors. |
|
|
Term
1) T or F Norepinephrine has hardly any effect if any on cardiac output |
|
Definition
1) T...maybe a slight decrease in cardiac output |
|
|
Term
With Dopamine DOSING is Essential to Desired Effect 1) < 5 mcg/kg/min =____ and ___ receptor activation 2) 5 to 10mcg/kg/min = beta 1 adrenergic effects...WHAT WOULD THIS MEAN? 3) > 10 mcg/kg/min = _____ adrenergic effects |
|
Definition
1) DA1 and DA2 (vasodilation) 2) Increased cardiac contractility and heart rate 3) alpha 1...Increased vasoconstriction |
|
|
Term
What are some adverse affects of Tx with Dopamine? (3) |
|
Definition
Adverse effects Tachycardia…be very careful with overdose Arrhythmogenic Digital ischemia – higher dose
|
|
|
Term
What are some adverse affects of PHENYLEPHRINE? |
|
Definition
Adverse effects Digital ischemia – SEVERE
Bradycardia??? it is possible
|
|
|
Term
Inotropic Agents (alter the strength of cardiac contractions) we discussed are: |
|
Definition
Dobutamine Milrinone Isoproterenol |
|
|
Term
T or F Dobutamine 1) Increases CO 2) Vasoconstricts 3) Is a Beta 1 and 2 antagonist? 4) Tachyarrhythmia, arrhythmias, and tachycardias may be adverse effects |
|
Definition
True False it vasodilates False it is a beta 1 and beta 2 agonist True |
|
|
Term
1) Milrinone is administered how? 2) Maintenance dosing needed? 3) What might we have to adjust for? 4) What is the mechanism of action for Milrinone 5) What are some adverse side effects? |
|
Definition
1) 50 micrograms/kilogram over 10 minutes 2) Yes....0.375 to 0.75 mcg/kg/minute... 3) Renal Insufficiency 4) Phosphodiesterease inhibitor...increases CO and reduces after-load via vasodilation 5) Hypotension, Ventricular arrhythmias, Thrombocytopenia |
|
|
Term
When should we use Isoprotenol? |
|
Definition
Don't...its a bad drug and nobody uses it |
|
|
Term
1)WHy might corticosteroids help us with shock therapy? |
|
Definition
1)They upregulate the sympathetic nervous system which help the other drugs effective (prevent a tolerance to drug efficacy) |
|
|
Term
Vasopressin 1) Mechanism(3) 2) Dosing 3) Adverse effects:
|
|
Definition
1) i)Increase in SVR (systemic vascular resistence) via V1 receptor mediated vasoconstriction ii) Increase responsiveness to catecholamine iii)Inhibition of of vascular smooth muscle nitric oxide production 2) 0.01 – 0.04 units/min 3) Decreased splanchnic blood flow • Arrhythmias • Peripheral necrosis • High dose = cardiotoxic |
|
|
Term
1)How does PAD usually present clinically? 2) What are Treatment goals? 3) Whare are the 2 drugs we talked about for Tx PAD? |
|
Definition
1) Intermittent claudication..usually resolves with rest and is exacerbated by exercise. 2) Reduction of confounding variables Increase walking distance, walking duration, pain-free walking Improvement of comorbid conditions 3) Cilostazol and Pentoxifylline
|
|
|
Term
How does Pentoxifylline work? How well does it work? |
|
Definition
1)Alters RBC flexibility so they may squeeze by the blockage areas 2) Not very well...but LOPA (leave old people alone) |
|
|
Term
1) What are the Goals for Treating Chronic HF? |
|
Definition
1)Desired Outcomes Improve the patients quality of life Reduce symptoms Reduce hospitalizations Slow progress of disease Prolong survival
|
|
|
Term
Drug Therapy for HF depends on ACC/AHA stages... 1) for Stage A 2) for Stage B 3) for Stage C |
|
Definition
A (Patients with high risk for developing HF)= ACEI
B (Patients with structural HD but no HF symptoms) = ACEI + β blocker C (Patients with structural HD and current HF symptoms) = ACEI + β blocker + digoxin + diuretics ± aldosterone antagonist ± ARB or dihydroperidine Ca channel blocker ± nitrates
|
|
|
Term
1) In what 2 ways does the ACE inhibitor Fct? |
|
Definition
1) Blocks Ang 1 from becoming Ang 2...causes vasoconstriction of renal arterioles...hench raising systemic blood pressure 2) Decreases the production of Aldosterone...which is responsible for Na reabsorbtion ULTIMATELY these effects reduce cardiac remodeling, fibrosis, apoptosis, hypertrophy, vasoconstriction, sodium and water retention |
|
|
Term
Beta-Blockers (class II) and HF 1) Not all are equal...which 3 should we stick with ? 2) Outcomes good for which HD patients? 3) mechanism? |
|
Definition
1) Carvedilol Metoprolol XL Bisoprolol 2) Stable (gives them fewer hospitalizations and increases survival rates) 3) Act to decrease teh Sympathetic Nervous System. |
|
|
Term
1) ACE Inhibitor side effects? 2) Any difference in Heavy and Light dosing? |
|
Definition
1) Side effects COUGH!!!... (due to prevention of breakdown of Bradykinin.) Angioedema …uncommon Hyperkalemia…RX diuretics… Renal dysfunction 2) ATLAS Low dose vs. high dose No difference in mortality 24% lower hospitalization in the high dose group…KEEPS PEOPLE OUT OF THE HOSPITAL>>>better quality of life. |
|
|
Term
1) Why do pts on ACE inhibitors need diuretics? 2) What do we watch for? 3) T/F Diastolic HF requires higher diuretic dosages? 4) Rank the following diuretics in potency Torsemide Bumetanide Furosemide |
|
Definition
1) Hyperkalcemia due to natriuresis 2) Hypokalcemia 3) False 4) Bumentanide>Toresemide>Furosemide |
|
|
Term
Digoxin is a positive inotropic drug used for over 200 years for rate control...it is more often used for its neurohormonal effects. 1) In small doses (~ ___-___ng/ml) it can be helpful, but it has many side effects that must be monitored.2) These are... |
|
Definition
1) 0.5– 1 2) Diarrhea, nausea, vomiting, mental status changes, visual disturbances (yellow and green visual rings), fatigue, ventricular arrhythmias, AV block
|
|
|
Term
1)Aldosterone Antagonists are good for which group according to the RALES trial ? 2)They may reduce mortality by up to ___% 3) Mechanism? 4) What do 10-20% of pts develop? 5) If using with ACE inhibitors..what do we watch out for? |
|
Definition
1)Add in patients with NYHA III – IV SEVERE SYMPTOMATIC DZ 2) 30% 3) i)Potassium Diuretic ii) Mineralocorticoid blockers. iii)Decreases collagen deposition during cardiac remodeling 4)Gynecomastia (Bob...Bob had bitch tits) 5) Hyperkalemia |
|
|
Term
1) Angiotensin II Receptor Blockers (ARBs) are good for which group of HF pts? 2) Nitrates and Hydralizines are good for which group 3) Specifically, which group does better on Nitrates/Hydralazines than ACEI or ARBs |
|
Definition
1) Those who cannot deal with the cough 2) those who cannot be tx with ACEI or ARBs 3) African Americans |
|
|
Term
1) How do Nitrates work?
2) How do Hydralazines work? 3) Common side effects of both include |
|
Definition
1) Nitrates = vasodilatation (increased cGMP in smooth muscle) = preload reduction 2) Hydralazine = arterial smooth muscle vasodilator = SVR reducation 3) Headache, nausea, vomiting |
|
|
Term
Decompensated Heart Failure (body's compensation mechanisms no longer suffice) 1) What is subset I 2) What is subset II..how do u treat? 3) What is subset III 4) What is subset IV |
|
Definition
Subset I Normal
Subset II “Wet failure” = Pulmonary congestion Reduce preload with Diuretics, nitroglycerin, nesiritide
Subset III “Dry failure” = hypoperfusion with no congestion May need fluids. Need Positive inotropic agents Dobutamine, Milrinone
Subset IV “Wet failure” + “Dry Failure” = hypoperfusion + congestion Diuretics + inotropic agents
|
|
|
Term
1) Dobutamine should be used on which subset of DHF pts? 2) What do we need to watch for? 3) Can we easily ween these pts off Dobutamine? |
|
Definition
1) III (Dry failure) 2) Tachycardia 3) No...you can send them into HF |
|
|
Term
1)Milrinone is used to Tx which Class of DHF? 2) Increases____ levels to act as a positive intropic agent 3) T/F...Short half-life 4) Side effects? |
|
Definition
1) III 2) cAMP 3) False, Long half life 4) Hypotension, thrombocytopenia, arrhythmias |
|
|
Term
Nitropurside: 1) Mechanism? 2) Relationship to other inotropic agents? 3)Side effects? |
|
Definition
1) mixed arterial-venous vasodilator 2) Causes greater drop in preload 3) SEVER HYPOTENSION, CYANIDE and THIOCYANATE toxicity, Rebound Hypertension |
|
|
Term
Nitroglycerin and DHF 1) which subset is this the "mainstay for? 2) T/F Short half-life? 3) T/F Tolerance develops quickly 4) Side Effects? |
|
Definition
1) II (preload reduction for "wet subset") 2) True 3) True 4) Headache, tachyphylaxis, hypotension |
|
|
Term
VT and DTE: 1) t/f ...Unfractionated Heparin can beabsorbed well subcutaneously? 2) side effects? 3) What do we need to monitor? (4 things) |
|
Definition
1) IV 2) HIT,osteoporosis, alopecia, suppressed aldosterone production 3) aPTT (activated partial thromboplastin time) ACT (activated clotting time) Anti-factor Xa activity Plasma Heparin concentrations |
|
|
Term
1) T/F ..LMW Heparin can is okay to be absorbed subcutaneously? 2) T/F it has a shorter half-life than Unfractionated? 3) requires less monitoring? 4) If factor Xa needs to be checked do so __ hours after bolus. |
|
Definition
1) True 2) False...longer halflife than unfractionated..give bid 3) True must more specific with a 4:1 (Xa:IIa ratio) compared to unfractionated. 4) 4 |
|
|
Term
1) Fondaparinux (Arixtra) 2) T/F no direct effect on thrombin 3) T/F ..Short half life 4) Eliminated through the ____ unchanged? 5) What is the major problem with this drug? |
|
Definition
1) More selective pentasaccharide anticoagulant selectively and directly inhibits factor __activity. 2) T 3) False...long 4) urine 5) It binds irreversibly...watch for bleeding |
|
|
Term
Direct Thrombin inhibitors: 1) Name the 3 marketed in US 2) Which binds irreversibly? |
|
Definition
1)Lepirudin Bivailirudin Argatroban 2) Lepirudin |
|
|
Term
Lepirudin 1) What is its advantage? 2) What is the disadvantage |
|
Definition
1) undergoes Hoffman reduction so we don't need to worry about the liver or kidneys (for those that are damaged) 2) Up to 40% of pts develop Antibodies to Lepirudine when treated for 10 days |
|
|
Term
1) What is the target group for Bivailirudin (Angiomax) therapy? 2) How does Argatroban bind to thrombin? 3) What is the name of teh drug not currently marked in the US but similiar in mechanism to Argatroban? |
|
Definition
1) Only approved for treatment of patients undergoing percutaneous transluminal angioplasty (PTA) 2) Reversibly binds only to the active catalytic site of thrombin 3) Ximelagatran |
|
|
Term
1) What is the most widely prescribed Anticoagulant in North America? 2) How does it work? 3) T/F...very narrow therapeutic index? 4) Most pts can start at __ mg a day 5) Why not safe for pregnant women? |
|
Definition
1) Warfarin...=Rat poison 2) Inhibits vitamin K reductase....decreases factors VII, IX, X, II protein C and Protein S. 3) True 4) Five 5) Fetal hemorrhagic and teratrogenic complications |
|
|
Term
1) Which -mycins does Warfarin interact with? 2)Which antiarrhythmic drug does it intereact with? 3) Which antifungals? |
|
Definition
1) Erythro and Neo 2) Amiodarone 3) Miconazole, Metronidazole, Itraconazole |
|
|
Term
1) Warfarin users must eat foods high or moderately high in Vit__ sparingly and consistently. 2) What is the Goal INR for most Warfarin users? 3) How long do you have to wait for peak Warfarin effects to take hold? |
|
Definition
1) Vit K (brussels sprouts cabbage, collard greens) 2) 2-3 3) 3-5 Days |
|
|
Term
Thrombolytic Therapy: 1) What is only used in strokes? 2) __ hours after first symptoms present, there is no difference in using tPA vs. placebo according to the NINDS trial. 3) How is it administered usually? 4) T/F it also decreases teh risk of intracerebral hemorrhage 5) Any difference in mortalities with tPA and Placebo? |
|
Definition
1) Tissue Plasminogen activator or Alteplase® 2) 3 hours 3) IV 4) True ...(0.6% tPA) vs 6.4% (placebo) 5) No |
|
|
Term
1) How does tPA work? 2) Derivatives of tPA include (2) 3) Which has a longer half-life 4) If candidate is cleared for tPA administration, what dosage do you give them? |
|
Definition
1) Selectively activates firbrin-bound plasminogen 2) Reteplase and Tenecteplase 3) Tenecteplase (1 bolus) 4)0.9mg/kg over 1 hour (bolus 10% of dose) KNOW THIS DOSING |
|
|
Term
Stroke... Secondary Prevention you use what for.... 1) 1st line? 2) Cardioembolic? 3) All? |
|
Definition
First line Aspirin Plavix for those who have ASA allergies Clopidogrel Cadrioembolic Warfarin All ACE inhibitor + diuretic or ARB (angiotensin receptor blocker) for blood pressure control Statin
|
|
|